Inhibition of uropathogens by lactic acid bacteria isolated from dairy foods and cow’s intestine in western Nigeria
- 16 June 2009
- journal article
- research article
- Published by Springer Nature in Archives of Microbiology
- Vol. 191 (8) , 639-648
Abstract
A total of 96 lactic acid bacteria (LAB) were isolated from African indigenous fermented products and cow’s intestines to study their inhibitory capability against multi-drug-resistant uropathogens. Escherichia coli accounted for approximately 45% of isolated uropathogens, followed by Staphylococcus spp. (20%). The Gram negative uropathogens were highly resistant to quinolones, co-trimoxazole, teicoplanin and some β-lactams, while the Staphylococcus spp. showed high resistance to aminoglycosides, β-lactams and macrolides. Twenty-four LAB isolates were selected based on their antimicrobial activity against two uropathogenic Staphylococcus aureus strains and bacteriocin production. LAB strains showing antimicrobial activity were grouped into smaller groups through amplified ribosomal DNA restriction analysis (ARDRA). Representative strains were identified as Weissella spp., Enterococcus faecium, Lactococcus lactis and Lactobacillus brevis through sequencing of 16S rDNA. The Weissella spp. and L. brevis strains demonstrated remarkable inhibitory activity against seven strains of Gram negative uropathogens. Two strains of L. lactis produced a bacteriocin-like inhibitory substance active against Lactobacillus sakei. In this study, an unusual high rate of co-trimoxazole, quinolones and macrolides resistance among uropathogens from south west Nigeria was discovered. Based on their sensitivity to Weissella spp., there is a potential for using these LAB as a natural approach for the protection against the uropathogens assayed.Keywords
This publication has 19 references indexed in Scilit:
- Contemporary Management of Uncomplicated Urinary Tract InfectionsDrugs, 2008
- Proposed Model: Mechanisms of Immunomodulation Induced by Probiotic BacteriaClinical and Vaccine Immunology, 2007
- Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional useJournal of Antimicrobial Chemotherapy, 2007
- Effect of Weissella cibaria Isolates on the Formation of Streptococcus mutans BiofilmCaries Research, 2006
- Growth and lactic acid production by vaginal Lactobacillus acidophilus CRL 1259, and inhibition of uropathogenic Escherichia coliJournal of Medical Microbiology, 2003
- Defense factors of vaginal lactobacilliAmerican Journal of Obstetrics and Gynecology, 2001
- Antimicrobial Resistance Among Uropathogens that Cause Community‐Acquired Urinary Tract Infections in Women: A Nationwide AnalysisClinical Infectious Diseases, 2001
- Lactobacillus coryniformis subsp. coryniformis Strain Si3 Produces a Broad-Spectrum Proteinaceous Antifungal CompoundApplied and Environmental Microbiology, 2001
- Use of ciprofloxacin in developing countriesThe Pediatric Infectious Disease Journal, 1997
- Trimethoprim and sulfonamide resistanceAntimicrobial Agents and Chemotherapy, 1995